Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

23.82 -0.13 (-0.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 465,643
Open 24.08
Bid (Size) 20.00 (200)
Ask (Size) 24.80 (100)
Prev. Close 23.95
Today's Range 23.50 - 24.18
52wk Range 16.64 - 29.52
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH): Strongest Q2 Results from the Generic Pharmaceuticals Group
Let’s dig into the relative performance of Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers as we unravel the now-completed Q2 generic pharmaceuticals e... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Healthcare Stocks We Keep Off Our Radar
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory

Performance

YTD
-10.0%
-10.0%
1 Month
+14.2%
+14.2%
3 Month
+22.7%
+22.7%
6 Month
+25.4%
+25.4%
1 Year
-11.8%
-11.8%

More News

Read More
News headline image
1 Cash-Producing Stock on Our Buy List and 2 We Question
Via StockStory
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stands Out as a Quality Investing Candidate ↗
Via Chartmill
News headline image
Amphastar (AMPH) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Amphastar Pharmaceuticals (NASDAQ:AMPH) Beats Q2 Earnings Estimates, Shares Rise After Hours ↗
Via Chartmill
News headline image
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
Via StockStory
Topics Earnings
News headline image
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results
Via StockStory
News headline image
Amphastar Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal ↗
Via Chartmill
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026
Via StockStory
News headline image
What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings
Via StockStory
Topics Artificial Intelligence
News headline image
1 Value Stock to Own for Decades and 2 Facing Challenges
Via StockStory
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds
Via StockStory
News headline image
3 Reasons AMPH is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Supply Chain
News headline image
3 Stocks Under $50 We Keep Off Our Radar
Via StockStory
Topics Energy
News headline image
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges
Via StockStory
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
Via StockStory
Topics Artificial Intelligence
News headline image
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth ↗
Via MarketBeat
News headline image
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag ↗
Via MarketBeat
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
Via ACCESS Newswire
News headline image
3 Stocks Under $50 with Open Questions
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
Via StockStory
News headline image
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook ↗
Via MarketBeat
News headline image
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
Via StockStory
Topics Earnings

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 23.82
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 09/17/26 04:00 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.15B
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.